Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A

Affiliations

• ¹ Reference Center for Neuromuscular Disorders and ALS, CHU La Timone, Marseille, France. Shahram.ATTARIAN@ap-hm.fr.
• ² Department of Neurology, Medical Park Bad Feilnbach, Bad Feilnbach, Germany.
• ³ Columbia University Medical Center, The Neurological Institute, New York, USA.
• ⁴ French Reference Center for Rare Peripheral Neuropathies, Service de Neurologie Adulte, APHP, CHU Bicêtre, Le Kremlin Bicêtre, France.
• ⁵ Department of Neurology, University Hospitals Leuven, KU, Leuven, Belgium.
• ⁶ Center for Brain & Disease Research, VIB, Leuven, Belgium.
• ⁷ Department of Neurology, Hackensack University Medical Center, Hackensack, USA.
• ⁸ Department of Neurology, Saint Louis University School of Medicine, St. Louis, USA.
• ⁹ Neuromuscular Unit, Neurology Department, Bellvitge University Hospital, Barcelona, Spain.
• ¹⁰ Neurometabolic Diseases Group, Bellvitge Research Institute (IDIBELL) and CIBERER, Barcelona, Spain.
• ¹¹ U1171, Centre de référence des maladies neuromusculaires Nord Est Ile de France, Hôpital Salengro CHU de Lille, Lille, France.
• ¹² Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.
• ¹³ Centre de Référence Maladies Neuromusculaires AOC, Filnemus, Euro-NMD, CHU Nantes, Hôtel-Dieu, Nantes, France.
• ¹⁴ Clinical Neuroscience Research Unit, University of Minnesota, Minneapolis, USA.
• ¹⁵ University of Michigan Health System, Ann Arbor, MI, USA.
• ¹⁶ Department of Neurology, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
• ¹⁷ Department of Neurology, Brigham and Women's Hospital, Boston, USA.
• ¹⁸ St. Luke's Rehabilitation Institute, Physical Medicine and Rehabilitation, Spokane, USA.
• ¹⁹ CHU Dupuytren, Limoges, France.
• ²⁰ University of Kansas Medical Center, Kansas City, USA.
• ²¹ Department of Neuromuscular Medicine, Hospital for Special Care, New Britain, USA.